In addition to anti-tumor effects, sinularin has been shown to inhibit the production of inflammatory mediators such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) stimulated by lipopolysaccharide (LPS) [7]. This evidence concerns the gene PTGS2 and neoplasm.